Gables Capital Management Inc. In Med Pharmaceuticals Inc. Transaction History

Gables Capital Management Inc.

  • $204 Million
  • Q4 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 02, 2023
BUY
$0.69 - $1.22 $0 - $1
1 New
1 $0
Q3 2022

Oct 31, 2022
BUY
$5.11 - $18.78 $5 - $18
1 New
1 $0

Others Institutions Holding INM

# of Institutions
4
Shares Held
790K
Call Options Held
0
Put Options Held
0
View Full List

About InMed Pharmaceuticals Inc.

INM Quotes by TradingView
  • Ticker INM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 908,761
  • Market Cap $2.87M
  • Description
  • InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, researches and develops cannabinoid-based therapies. The company's lead product is INM-755, a cannabinol topical cream, which is in a second Phase I clinical trials for the treatment of epidermolysis bullosa. The company is also involved in developing INM-088, which is in precl...
More about INM
Track This Portfolio

Track Gables Capital Management Inc. Portfolio

Follow Gables Capital Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gables Capital Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Gables Capital Management Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email